Red ginseng gains attention for immune health amid flu surge

Red ginseng is gaining attention as a potential remedy for immune health amid a surge in flu cases. This surge, which has seen the number of patients with influenza-like illnesses nearly double, is prompting market interest in products that may help support immune health. As a result, companies that produce or sell red ginseng may see increased demand and potentially higher sales. This could have a positive impact on their stock prices.

Why it matters

The flu season is arriving earlier than usual, creating demand for immune-boosting products. Red ginseng is gaining attention as a potential solution, which could benefit health-related stocks.

Market impact

Transmission channels

Likely winners & losers

Explore the intelligence

MeridStreet does not reproduce source articles. The summary and analysis above are generated by MeridStreet from public headlines and its own market model; the original reporting belongs to The Korea Times. For information only — not financial advice.